Is PGEN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PGEN. It does not provide personalized investment advice.

PGEN (Precigen, Inc. Common Stock) Stock Analysis - Financials

Precigen, Inc. Common Stock (PGEN) is a publicly traded Healthcare sector company. As of September 21, 2026, PGEN trades at $7.84 with a market cap of $2.79B and a P/E ratio of -7.42. PGEN moved +0.78% today. Year to date, PGEN is +86.12%; over the trailing twelve months it is +104.74%. Its 52-week range spans $1.11 to $8.04. Analyst consensus is buy with an average price target of $18.00. Rallies surfaces PGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PGEN's key financials?

PGEN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PGEN recently traded at $7.84. Market cap is $2.79B. P/E ratio is -7.42. Revenue is $85.72M.

PGEN Key Metrics

Key financial metrics for PGEN
Metric	Value
Price	$7.84
Market Cap	$2.79B
P/E Ratio	-7.42
EPS	$-1.04
Dividend Yield	0.00%
52-Week High	$8.04
52-Week Low	$1.11
Volume	85.56K
Avg Volume	0
Revenue (TTM)	$85.72M
Net Income	$-157.71M
Gross Margin	0.00%

PGEN Analyst Consensus

1 analysts cover PGEN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $18.00.

Common questions about PGEN

What are PGEN's key financials?: PGEN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PGEN recently traded at $7.84. Market cap is $2.79B. P/E ratio is -7.42. Revenue is $85.72M.
Is PGEN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PGEN. It does not provide personalized investment advice.